Latest News about Moderna Inc
Recent news which mentions Moderna Inc
Cramer's Lighting Round: Sell AMC
May 24, 2024
From CNBC.com News
Here's how U.S. health officials are responding to bird flu in humans after second case
May 24, 2024
From CNBC.com News
From CNBC.com News
Novavax stock jumps 50% as Sanofi deal kicks off turning point for struggling vaccine maker
May 13, 2024
From CNBC.com News
From CNBC.com News
Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop combination shots
May 10, 2024
From CNBC.com News
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
May 02, 2024
From CNBC.com News
5 things to know before the stock market opens Monday
April 29, 2024
From CNBC.com News
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
April 25, 2024
From CNBC.com News
From CNBC.com News
Moderna moves three vaccines into final stage trials as it works to rebound from Covid slump
March 27, 2024
From CNBC.com News
Moderna says new Covid vaccine showed stronger immune response than current shot in study
March 26, 2024
From CNBC.com News
From CNBC.com News
5 things to know before the stock market opens Thursday
February 22, 2024
From CNBC.com News
From CNBC.com News
5 things to know before the stock market opens Tuesday
February 20, 2024
From CNBC.com News
GSK posts blowout RSV vaccine sales, raises outlook as shots give big pharma a boost
January 31, 2024
From CNBC.com News
Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
January 28, 2024
From CNBC.com News
Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
January 26, 2024
From CNBC.com News
Treasury yields fall ahead of economic growth numbers
January 25, 2024
From CNBC.com News
From CNBC.com News
Treasury yields fractionally higher ahead of key data releases
January 23, 2024
From CNBC.com News
Treasury yields retreat ahead of big week for economic data
January 22, 2024
From CNBC.com News
Cramer's Lighting Round: 'Hold on to' BioNTech
January 16, 2024
From CNBC.com News
Moderna Covid vaccine sales plunge by two-thirds in 2023, but meet company's $6 billion forecast
January 08, 2024
From CNBC.com News
Jim Cramer reviews the worst performers on the Nasdaq-100 in 2023
January 04, 2024
From CNBC.com News
CNBC Daily Open: A bumpy start to the year, but don’t lose hope
January 03, 2024
From CNBC.com News
CNBC Daily Open: A disappointing start to the year, but long-term view’s still bright
January 02, 2024
From CNBC.com News
Moderna stock pops after Oppenheimer says Covid shot maker could launch more products over next two years
January 02, 2024
From CNBC.com News
Here are the big health sector themes to watch next year
December 22, 2023
From CNBC.com News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.